1. Home
  2. PIRS vs YQ Comparison

PIRS vs YQ Comparison

Compare PIRS & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PIRS
  • YQ
  • Stock Information
  • Founded
  • PIRS 2001
  • YQ 2012
  • Country
  • PIRS United States
  • YQ China
  • Employees
  • PIRS N/A
  • YQ N/A
  • Industry
  • PIRS Biotechnology: Pharmaceutical Preparations
  • YQ Other Consumer Services
  • Sector
  • PIRS Health Care
  • YQ Real Estate
  • Exchange
  • PIRS Nasdaq
  • YQ Nasdaq
  • Market Cap
  • PIRS 22.4M
  • YQ 21.1M
  • IPO Year
  • PIRS N/A
  • YQ 2020
  • Fundamental
  • Price
  • PIRS $15.93
  • YQ $1.90
  • Analyst Decision
  • PIRS
  • YQ
  • Analyst Count
  • PIRS 0
  • YQ 0
  • Target Price
  • PIRS N/A
  • YQ N/A
  • AVG Volume (30 Days)
  • PIRS 37.6K
  • YQ 20.1K
  • Earning Date
  • PIRS 11-13-2024
  • YQ 12-04-2024
  • Dividend Yield
  • PIRS N/A
  • YQ N/A
  • EPS Growth
  • PIRS N/A
  • YQ N/A
  • EPS
  • PIRS N/A
  • YQ N/A
  • Revenue
  • PIRS $1,352,000.00
  • YQ $25,517,759.00
  • Revenue This Year
  • PIRS N/A
  • YQ N/A
  • Revenue Next Year
  • PIRS N/A
  • YQ N/A
  • P/E Ratio
  • PIRS N/A
  • YQ N/A
  • Revenue Growth
  • PIRS N/A
  • YQ N/A
  • 52 Week Low
  • PIRS $6.20
  • YQ $1.41
  • 52 Week High
  • PIRS $22.32
  • YQ $3.55
  • Technical
  • Relative Strength Index (RSI)
  • PIRS 43.29
  • YQ 41.86
  • Support Level
  • PIRS $15.15
  • YQ $1.86
  • Resistance Level
  • PIRS $16.97
  • YQ $1.99
  • Average True Range (ATR)
  • PIRS 0.72
  • YQ 0.12
  • MACD
  • PIRS -0.08
  • YQ 0.01
  • Stochastic Oscillator
  • PIRS 30.75
  • YQ 34.88

About PIRS Pieris Pharmaceuticals Inc.

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.

Share on Social Networks: